SCHEMBL29566941

SCHEMBL29566941

Cn1cc(S(=O)(=O)Nc2nc(Oc3ccc(N4CCNCC4)cc3)cc(C3CCCC3)n2)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 10/20 0.38
▸ CCND1 P24385 6/20 0.38
▸ CDK2 P24941 3/20 0.38
▸ CDK1 P06493 2/20 0.38
▸ CCNB1 P14635 2/20 0.38
▸ CCNE1 P24864 2/20 0.38
▸ CCND3 P30281 3/20 0.37
▸ HTR6 P50406 1/20 0.36
▸ GUSB P08236 5/20 0.36
▸ FLT3 P36888 3/20 0.35
▸ CDK6 Q00534 2/20 0.35
▸ RIPK2 O43353 1/20 0.35
▸ ACVR1 Q04771 1/20 0.35
▸ NOD2 Q9HC29 1/20 0.35
▸ CCND2 P30279 1/20 0.35
▸ FGFR1 P11362 1/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ FGFR2 P21802 1/20 0.34
▸ FGFR4 P22455 1/20 0.34
▸ FGFR3 P22607 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309695 1.00 CDK4 (0.38) CDK4CCND1CDK2CDK1CCNB1
SCHEMBL26810553 0.88 HTR6 (0.36) HTR6GUSBFLT3RIPK2ACVR1
SCHEMBL29566429 0.86 RIPK2 (0.37) CDK4CCND1CDK2CDK1CCNB1
SCHEMBL24310567 0.86 RIPK2 (0.37) CDK4CCND1CDK2CDK1CCNB1
SCHEMBL26807780 0.86 LTA4H (0.47) CDK2HTR6GUSBFLT3CDK6
SCHEMBL24309513 0.86 LTA4H (0.41) HTR6GUSBFLT3RIPK2ACVR1
SCHEMBL29567157 0.86 LTA4H (0.41) HTR6GUSBFLT3RIPK2ACVR1
SCHEMBL26807778 0.86 HTR3E (0.46) HTR6GUSBRIPK2ACVR1NOD2
SCHEMBL26807760 0.85 LTA4H (0.48) HTR6GUSBRIPK2ACVR1NOD2
SCHEMBL26807484 0.85 HTR1A (0.43) HTR6FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback